Kjellin M, Wesslén T, Löfblad E, Lennerstrand J, Lannergård A. The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort. ujms [Internet]. 2018Mar.14 [cited 2024Nov.28];123(1):50–56. Available from: https://ujms.net/index.php/ujms/article/view/5824